a flurry of new drug development and approvals in breast cancer: 2022 esmo florida
Published 1 year ago • 133 plays • Length 1:57
Download video MP4
Download video MP3
Similar videos
-
2:40
emergence of antibody-drug conjugates in metastatic breast cancer: 2022 esmo florida
-
2:37
genomic classifiers in breast cancer: prognostic and predictive information: 2022 esmo florida
-
0:59
using genomic assays for clinical decision making in early breast cancer: 2022 esmo florida
-
0:33
treating patients with breast cancer and a brca 1/2 mutation: 2022 esmo florida
-
22:47
early stage breast cancer | 2022 oneoncology conference
-
11:12
her2-low breast cancer: destiny or good science?
-
1:21:32
antibody–drug conjugates for solid tumors: progress, possibilities, and implications for care
-
1:35:38
ucsf bay area breast cancer forum: "updates from asco 2024”
-
1:08
refining classification and staging in breast cancer – biology matters alot: 2022 esmo florida
-
0:30
new classifications and staging in breast cancer | jodi widner, md | esmo22 colorado
-
53:15
will new antibody drug conjugates cure bladder cancer?
-
1:23
familial syndromes and the benefits of multi-gene panel testing in breast cancer: 2022 esmo florida
-
6:24
esmo 2024 conference wrap-up with rebecca dent, md, frcp, scientific chair
-
1:45
clincal trial highlights in breast cancer at esmo 2022
-
0:51
“moving the needle” in the metastatic breast cancer setting: 2022 esmo florida
-
18:38
breast cancer esmo 2024 highlights: key studies discussed natalee, keynote 522, destiny-breast12
-
0:43
an increasing number of agents with cns penetrance in lung cancer: 2022 esmo florida
-
17:51
eversana and pharmaphorum in conversation: esmo 2024
-
0:37
esmo22 congress review of controversies in care | manojkumar bupathi, md, ms | esmo22 colorado
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
Clip.africa.com - Privacy-policy